Literature DB >> 8500268

The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus.

C E Siegert1, M R Daha, A J Swaak, E A van der Voort, F C Breedveld.   

Abstract

The aim of the present study was to assess the relationship between age and titers of autoantibodies to C1q (C1qAb) in individuals randomly selected out of the general population and in systemic lupus erythematosus (SLE) patients. Serum samples of 659 randomly selected individuals and 169 SLE patients were divided into 6 age groups from 20 to 79 years. IgG and IgA C1qAb titers were measured by ELISA. The highest titers of IgG and IgA C1qAb in sera of randomly selected individuals were found in the oldest age groups. In serum of SLE patients the highest titers of IgG C1qAb were found in the youngest age groups, whereas IgA C1qAb titers did not change with aging. It is concluded that the distribution pattern of IgG and IgA C1qAb titers in serum of individuals randomly selected out of the general population is similar to that of other autoantibodies. The increased titers of IgG C1qAb in serum of young patients with SLE suggest a role of these antibodies in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500268     DOI: 10.1006/clin.1993.1066

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  14 in total

Review 1.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 3.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review.

Authors:  Andrew Buck; Jim Christensen; Morgan McCarty
Journal:  J Clin Aesthet Dermatol       Date:  2012-01

5.  Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus.

Authors:  Carlos Geraldo Moura; Isabella Lima; Lúcio Barbosa; Daniel Athanazio; Eliana Reis; Mitermayer Reis; Rufus W Burlingame; Mittermayer B Santiago
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  Anti-C1q in systemic lupus erythematosus.

Authors:  G Stojan; M Petri
Journal:  Lupus       Date:  2016-07       Impact factor: 2.911

7.  Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.

Authors:  J E Salmon; S Millard; L A Schachter; F C Arnett; E M Ginzler; M F Gourley; R Ramsey-Goldman; M G Peterson; R P Kimberly
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

8.  Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies.

Authors:  L A Trouw; M A Seelen; J M G J Duijs; H Benediktsson; C Van Kooten; M R Daha
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

9.  Anti-C1q antibodies in systemic lupus erythematosus.

Authors:  A-M Orbai; L Truedsson; G Sturfelt; O Nived; H Fang; G S Alarcón; C Gordon; Jt Merrill; P R Fortin; I N Bruce; D A Isenberg; D J Wallace; R Ramsey-Goldman; S-C Bae; J G Hanly; J Sanchez-Guerrero; A E Clarke; C B Aranow; S Manzi; M B Urowitz; D D Gladman; K C Kalunian; M I Costner; V P Werth; A Zoma; S Bernatsky; G Ruiz-Irastorza; M A Khamashta; S Jacobsen; J P Buyon; P Maddison; M A Dooley; R F Van Vollenhoven; E Ginzler; T Stoll; C Peschken; J L Jorizzo; J P Callen; S S Lim; B J Fessler; M Inanc; D L Kamen; A Rahman; K Steinsson; A G Franks; L Sigler; S Hameed; N Pham; R Brey; M H Weisman; G McGwin; L S Magder; M Petri
Journal:  Lupus       Date:  2014-08-14       Impact factor: 2.911

10.  Anti-C1q autoantibodies, novel tests, and clinical consequences.

Authors:  Michael Mahler; Rosanne A van Schaarenburg; Leendert A Trouw
Journal:  Front Immunol       Date:  2013-05-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.